Annual Cash & Cash Equivalents
$4.49 M
+$2.18 M+94.29%
December 31, 2023
Summary
- As of February 7, 2025, GCTK annual cash & cash equivalents is $4.49 million, with the most recent change of +$2.18 million (+94.29%) on December 31, 2023.
- During the last 3 years, GCTK annual cash & cash equivalents has fallen by -$5.33 million (-54.27%).
- GCTK annual cash & cash equivalents is now -54.27% below its all-time high of $9.82 million, reached on December 31, 2020.
Performance
GCTK Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Cash And Cash Equivalents
$346.00 K
+$187.00 K+117.61%
September 30, 2024
Summary
- As of February 7, 2025, GCTK quarterly cash and cash equivalents is $346.00 thousand, with the most recent change of +$187.00 thousand (+117.61%) on September 30, 2024.
- Over the past year, GCTK quarterly cash and cash equivalents has dropped by -$4.15 million (-92.30%).
- GCTK quarterly cash and cash equivalents is now -97.21% below its all-time high of $12.42 million, reached on March 31, 2020.
Performance
GCTK Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash And Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
GCTK Cash And Cash Equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +94.3% | -92.3% |
| 3 y3 years | -54.3% | -95.1% |
| 5 y5 years | +4526.2% | -97.0% |
GCTK Cash And Cash Equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -25.9% | +94.3% | -96.1% | +117.6% |
| 5 y | 5-year | -54.3% | +972.1% | -97.2% | +117.6% |
| alltime | all time | -54.3% | +8249.4% | -97.2% | +1900.0% |
GlucoTrack Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $346.00 K(+117.6%) |
| Jun 2024 | - | $159.00 K(-89.4%) |
| Mar 2024 | - | $1.50 M(-66.7%) |
| Dec 2023 | $4.49 M(+94.3%) | $4.49 M(-34.8%) |
| Sep 2023 | - | $6.89 M(-21.5%) |
| Jun 2023 | - | $8.77 M(+774.8%) |
| Mar 2023 | - | $1.00 M(-56.6%) |
| Dec 2022 | $2.31 M(-61.9%) | $2.31 M(-28.7%) |
| Sep 2022 | - | $3.24 M(-15.9%) |
| Jun 2022 | - | $3.85 M(-19.5%) |
| Mar 2022 | - | $4.79 M(-21.0%) |
| Dec 2021 | $6.06 M(-38.3%) | $6.06 M(-13.4%) |
| Sep 2021 | - | $7.00 M(-11.3%) |
| Jun 2021 | - | $7.89 M(-11.2%) |
| Mar 2021 | - | $8.89 M(-9.5%) |
| Dec 2020 | $9.82 M(+2244.4%) | $9.82 M(-8.3%) |
| Sep 2020 | - | $10.71 M(-7.0%) |
| Jun 2020 | - | $11.51 M(-7.3%) |
| Mar 2020 | - | $12.42 M(+2864.8%) |
| Dec 2019 | $419.00 K(+331.5%) | $419.00 K(-65.7%) |
| Sep 2019 | - | $1.22 M(-46.3%) |
| Jun 2019 | - | $2.28 M(+7338.9%) |
| Mar 2019 | - | $30.60 K(-68.5%) |
| Dec 2018 | $97.10 K | $97.10 K(-89.7%) |
| Sep 2018 | - | $941.90 K(+5344.5%) |
| Jun 2018 | - | $17.30 K(-94.5%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2018 | - | $314.40 K(+484.4%) |
| Dec 2017 | $53.80 K(-63.8%) | $53.80 K(-88.3%) |
| Sep 2017 | - | $461.70 K(-59.2%) |
| Jun 2017 | - | $1.13 M(-30.9%) |
| Mar 2017 | - | $1.64 M(+1001.5%) |
| Dec 2016 | $148.80 K(-75.6%) | $148.80 K(-78.6%) |
| Sep 2016 | - | $696.20 K(-50.5%) |
| Jun 2016 | - | $1.41 M(+969.6%) |
| Mar 2016 | - | $131.40 K(-78.4%) |
| Dec 2015 | $608.70 K(-89.6%) | $608.70 K(-71.1%) |
| Sep 2015 | - | $2.10 M(-40.1%) |
| Jun 2015 | - | $3.52 M(-25.1%) |
| Mar 2015 | - | $4.70 M(-19.4%) |
| Dec 2014 | $5.83 M(+144.3%) | $5.83 M(+32.8%) |
| Sep 2014 | - | $4.39 M(+644.1%) |
| Jun 2014 | - | $589.70 K(-63.5%) |
| Mar 2014 | - | $1.62 M(-32.2%) |
| Dec 2013 | $2.39 M(+339.1%) | $2.39 M(-32.2%) |
| Sep 2013 | - | $3.52 M(-18.6%) |
| Jun 2013 | - | $4.32 M(-18.9%) |
| Mar 2013 | - | $5.33 M(+880.0%) |
| Dec 2012 | $543.40 K(-71.3%) | $543.40 K(+197.9%) |
| Sep 2012 | - | $182.40 K(-75.9%) |
| Jun 2012 | - | $758.40 K(-46.4%) |
| Mar 2012 | - | $1.42 M(-25.3%) |
| Dec 2011 | $1.90 M | $1.90 M |
FAQ
- What is GlucoTrack annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for GlucoTrack?
- What is GlucoTrack annual cash & cash equivalents year-on-year change?
- What is GlucoTrack quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for GlucoTrack?
- What is GlucoTrack quarterly cash and cash equivalents year-on-year change?
What is GlucoTrack annual cash & cash equivalents?
The current annual cash & cash equivalents of GCTK is $4.49 M
What is the all time high annual cash & cash equivalents for GlucoTrack?
GlucoTrack all-time high annual cash & cash equivalents is $9.82 M
What is GlucoTrack annual cash & cash equivalents year-on-year change?
Over the past year, GCTK annual cash & cash equivalents has changed by +$2.18 M (+94.29%)
What is GlucoTrack quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of GCTK is $346.00 K
What is the all time high quarterly cash and cash equivalents for GlucoTrack?
GlucoTrack all-time high quarterly cash and cash equivalents is $12.42 M
What is GlucoTrack quarterly cash and cash equivalents year-on-year change?
Over the past year, GCTK quarterly cash and cash equivalents has changed by -$4.15 M (-92.30%)